Fig. 5From: Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancersThe concentration and ROC analysis of differential N-glycosylation sites identified in LUAD patients. A The concentration and ROC analysis of N-glycosylation sites with AUC > 80.0%. B, C The concentration and ROC analysis of N-glycosylation sites with AUC > 70.0%. **p < 0.01, ***p < 0.001Back to article page